Your browser doesn't support javascript.
loading
Nano-Infrared Imaging of Primary Neurons.
Freitas, Raul O; Cernescu, Adrian; Engdahl, Anders; Paulus, Agnes; Levandoski, João E; Martinsson, Isak; Hebisch, Elke; Sandt, Christophe; Gouras, Gunnar Keppler; Prinz, Christelle N; Deierborg, Tomas; Borondics, Ferenc; Klementieva, Oxana.
Afiliação
  • Freitas RO; Brazilian Synchrotron Light Laboratory (LNLS), Brazilian Center for Research in Energy and Materials (CNPEM), Campinas 13083-970, Sao Paulo, Brazil.
  • Cernescu A; Attocube Systems AG, Eglfinger Weg 2, 85540 Munich, Germany.
  • Engdahl A; Medical Microspectroscopy, Department of Experimental Medical Science, Lund University, 22180 Lund, Sweden.
  • Paulus A; Medical Microspectroscopy, Department of Experimental Medical Science, Lund University, 22180 Lund, Sweden.
  • Levandoski JE; Experimental Neuroinflammation Laboratory, Department of Experimental Medical Science, Lund University, 22180 Lund, Sweden.
  • Martinsson I; Brazilian Synchrotron Light Laboratory (LNLS), Brazilian Center for Research in Energy and Materials (CNPEM), Campinas 13083-970, Sao Paulo, Brazil.
  • Hebisch E; Experimental Dementia Research, Department of Experimental Medical Science, Lund University, 22180 Lund, Sweden.
  • Sandt C; Division of Solid State Physics and NanoLund, Lund University, 22100 Lund, Sweden.
  • Gouras GK; Synchrotron SOLEIL, L'Orme des Merisiers, CEDEX, 91192 Gif Sur Yvette, France.
  • Prinz CN; Experimental Dementia Research, Department of Experimental Medical Science, Lund University, 22180 Lund, Sweden.
  • Deierborg T; Division of Solid State Physics and NanoLund, Lund University, 22100 Lund, Sweden.
  • Borondics F; Experimental Neuroinflammation Laboratory, Department of Experimental Medical Science, Lund University, 22180 Lund, Sweden.
  • Klementieva O; Synchrotron SOLEIL, L'Orme des Merisiers, CEDEX, 91192 Gif Sur Yvette, France.
Cells ; 10(10)2021 09 27.
Article em En | MEDLINE | ID: mdl-34685539
ABSTRACT
Alzheimer's disease (AD) accounts for about 70% of neurodegenerative diseases and is a cause of cognitive decline and death for one-third of seniors. AD is currently underdiagnosed, and it cannot be effectively prevented. Aggregation of amyloid-ß (Aß) proteins has been linked to the development of AD, and it has been established that, under pathological conditions, Aß proteins undergo structural changes to form ß-sheet structures that are considered neurotoxic. Numerous intensive in vitro studies have provided detailed information about amyloid polymorphs; however, little is known on how amyloid ß-sheet-enriched aggregates can cause neurotoxicity in relevant settings. We used scattering-type scanning near-field optical microscopy (s-SNOM) to study amyloid structures at the nanoscale, in individual neurons. Specifically, we show that in well-validated systems, s-SNOM can detect amyloid ß-sheet structures with nanometer spatial resolution in individual neurons. This is a proof-of-concept study to demonstrate that s-SNOM can be used to detect Aß-sheet structures on cell surfaces at the nanoscale. Furthermore, this study is intended to raise neurobiologists' awareness of the potential of s-SNOM as a tool for analyzing amyloid ß-sheet structures at the nanoscale in neurons without the need for immunolabeling.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Espectrofotometria Infravermelho / Sistemas de Liberação de Fármacos por Nanopartículas / Neurônios Limite: Humans Idioma: En Revista: Cells Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Brasil

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Espectrofotometria Infravermelho / Sistemas de Liberação de Fármacos por Nanopartículas / Neurônios Limite: Humans Idioma: En Revista: Cells Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Brasil